Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV16/05/2024 | Var.-0.0800 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 245.4500EUR | -0.03% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | - | - | -2.07 | 6.28 | 2.52 | 0.74 | -2.26 | 2.63 | 9.16 | 3.09 | - |
| 2020 | -0.26 | -4.57 | -3.04 | 12.24 | 6.81 | 0.37 | -0.88 | 0.93 | 5.50 | -1.62 | 2.97 | 1.47 | +20.47% |
| 2021 | 1.20 | -4.18 | 3.11 | -0.16 | -1.08 | 6.25 | -1.03 | 5.97 | -2.06 | 3.45 | -3.82 | 2.85 | +10.28% |
| 2022 | -9.27 | -2.01 | 5.56 | -0.78 | -2.91 | 2.43 | 6.93 | -1.86 | -2.27 | 6.01 | 1.74 | -6.92 | -4.65% |
| 2023 | 0.31 | -1.64 | -1.12 | 1.12 | 0.82 | -2.28 | -0.25 | -0.55 | -2.93 | -6.28 | 5.72 | 4.36 | -3.22% |
| 2024 | 3.00 | 4.46 | 1.62 | -2.49 | 3.24 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 10.47% | 10.60% | 11.10% | 14.00% | 17.13% |
| Indice di Sharpe | 2.46 | 3.51 | 0.22 | 0.05 | 0.38 |
| Mese migliore | +4.46% | +5.72% | +5.72% | +6.93% | +12.24% |
| Mese peggiore | -2.49% | -2.49% | -6.28% | -9.27% | -9.27% |
| Perdita massima | -5.24% | -5.24% | -14.64% | -19.83% | -25.60% |
| Outperformance | - | - | - | - | - |
Tutte le quotazioni in EUR
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,400.9099 | +7.62% | +6.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,565.5000 | +7.75% | +6.45% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.9700 | +4.02% | -4.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.5000 | +5.81% | +17.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.3000 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.4500 | +6.23% | +14.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2900 | +6.27% | +2.13% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3300 | +7.17% | +4.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,796.0000 | +3.23% | +2.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.3600 | +5.69% | +16.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,114.3201 | +5.00% | -2.15% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.0600 | +7.14% | +17.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.4600 | +3.60% | -5.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.8900 | +7.16% | +4.72% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.1900 | +4.88% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,857.8800 | +6.15% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,884.1399 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.5300 | +6.26% | +2.11% |
Prestazione
| YTD | +10.07% | ||
|---|---|---|---|
| 6 mesi | +18.59% | ||
| 1 anno | +6.23% | ||
| 3 anni | +14.09% | ||
| 5 anni | +63.26% | ||
| 10 anni | - | ||
| Dall'inizio | +63.63% | ||
| Anno | |||
| 2023 | -3.22% | ||
| 2022 | -4.65% | ||
| 2021 | +10.28% | ||
| 2020 | +20.47% | ||
